Loading…

Hyperbranched Polyglycerols as Trimodal Imaging Agents: Design, Biocompatibility, and Tumor Uptake

Combining various imaging modalities often leads to complementary information and synergistic advantages. A trimodal long-circulating imaging agent tagged with radioactive, magnetic resonance, and fluorescence markers is able to combine the high sensitivity of SPECT with the high resolution of MRI o...

Full description

Saved in:
Bibliographic Details
Published in:Bioconjugate chemistry 2012-03, Vol.23 (3), p.372-381
Main Authors: Saatchi, Katayoun, Soema, Peter, Gelder, Nikolaus, Misri, Ripen, McPhee, Kelly, Baker, Jennifer H.E, Reinsberg, Stefan A, Brooks, Donald E, Häfeli, Urs O
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-a341t-75ec4ab37ee03ab64e65fb1908de9497eb7cc0d26161825290a50f4d41a184873
cites cdi_FETCH-LOGICAL-a341t-75ec4ab37ee03ab64e65fb1908de9497eb7cc0d26161825290a50f4d41a184873
container_end_page 381
container_issue 3
container_start_page 372
container_title Bioconjugate chemistry
container_volume 23
creator Saatchi, Katayoun
Soema, Peter
Gelder, Nikolaus
Misri, Ripen
McPhee, Kelly
Baker, Jennifer H.E
Reinsberg, Stefan A
Brooks, Donald E
Häfeli, Urs O
description Combining various imaging modalities often leads to complementary information and synergistic advantages. A trimodal long-circulating imaging agent tagged with radioactive, magnetic resonance, and fluorescence markers is able to combine the high sensitivity of SPECT with the high resolution of MRI over hours and days. The fluorescence marker helps to confirm the in vivo imaging information at the microscopic level, in the context of the tumor microenvironment. To make a trimodal long-circulating probe, high-molecular-weight hyperbranched polyglycerols (HPG) were modified with a suitable ligand for 111In radiolabeling and Gd coordination, and additionally tagged with a fluorescent dye. The resulting radiopharmaceutical and contrast agent was nontoxic and hemocompatible. Measured radioactively, its total tumor uptake increased from 2.6% at 24 h to 7.3% at 72 h, which is twice the increase expected due to tumor growth in this time period. Both in vivo MRI and subsequent histological analyses of the same tumors confirmed maximum HPG accumulation at 3 days post injection. Furthermore, Gd-derivatized HPG has an excellent contrast enhancement on T1-weighted MRI at 10× lower molar concentrations than commercially available Galbumin. HPG derivatized with gadolinium, radioactivity, and fluorescence are thus long-circulating macromolecules with great potential for imaging of healthy and leaky blood vessels using overlapping multimodal approaches and for the passive targeting of tumors.
doi_str_mv 10.1021/bc200280g
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_954768834</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2620967211</sourcerecordid><originalsourceid>FETCH-LOGICAL-a341t-75ec4ab37ee03ab64e65fb1908de9497eb7cc0d26161825290a50f4d41a184873</originalsourceid><addsrcrecordid>eNplkD1PwzAURS0EoqUw8AeQhcSA1MCz4yQOWykfrVQJhnaObMcJKUkc7GTIvyeopQxM7w1H5-pehC4J3BGg5F4qCkA55EdoTAIKHuOEHg8_MN8jHOgInTm3BYCYcHqKRpT6wCLCx0gu-kZbaUWtPnSK303Z52WvtDWlw8LhtS0qk4oSLyuRF3WOZ7muW_eAn7Qr8nqKHwujTNWItpBFWbT9FIs6xeuuMhZvmlZ86nN0konS6Yv9naDNy_N6vvBWb6_L-WzlCZ-R1osCrZiQfqQ1-EKGTIdBJkkMPNUxiyMtI6UgpSEJhxIBjUEEkLGUEUE445E_Qdc7b2PNV6ddm2xNZ-shMokDFoWc-2yAbneQssY5q7OkGRoK2ycEkp8xk8OYA3u1F3ay0umB_F1vAG52gFDuL-y_6BsArXpb</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>954768834</pqid></control><display><type>article</type><title>Hyperbranched Polyglycerols as Trimodal Imaging Agents: Design, Biocompatibility, and Tumor Uptake</title><source>American Chemical Society:Jisc Collections:American Chemical Society Read &amp; Publish Agreement 2022-2024 (Reading list)</source><creator>Saatchi, Katayoun ; Soema, Peter ; Gelder, Nikolaus ; Misri, Ripen ; McPhee, Kelly ; Baker, Jennifer H.E ; Reinsberg, Stefan A ; Brooks, Donald E ; Häfeli, Urs O</creator><creatorcontrib>Saatchi, Katayoun ; Soema, Peter ; Gelder, Nikolaus ; Misri, Ripen ; McPhee, Kelly ; Baker, Jennifer H.E ; Reinsberg, Stefan A ; Brooks, Donald E ; Häfeli, Urs O</creatorcontrib><description>Combining various imaging modalities often leads to complementary information and synergistic advantages. A trimodal long-circulating imaging agent tagged with radioactive, magnetic resonance, and fluorescence markers is able to combine the high sensitivity of SPECT with the high resolution of MRI over hours and days. The fluorescence marker helps to confirm the in vivo imaging information at the microscopic level, in the context of the tumor microenvironment. To make a trimodal long-circulating probe, high-molecular-weight hyperbranched polyglycerols (HPG) were modified with a suitable ligand for 111In radiolabeling and Gd coordination, and additionally tagged with a fluorescent dye. The resulting radiopharmaceutical and contrast agent was nontoxic and hemocompatible. Measured radioactively, its total tumor uptake increased from 2.6% at 24 h to 7.3% at 72 h, which is twice the increase expected due to tumor growth in this time period. Both in vivo MRI and subsequent histological analyses of the same tumors confirmed maximum HPG accumulation at 3 days post injection. Furthermore, Gd-derivatized HPG has an excellent contrast enhancement on T1-weighted MRI at 10× lower molar concentrations than commercially available Galbumin. HPG derivatized with gadolinium, radioactivity, and fluorescence are thus long-circulating macromolecules with great potential for imaging of healthy and leaky blood vessels using overlapping multimodal approaches and for the passive targeting of tumors.</description><identifier>ISSN: 1043-1802</identifier><identifier>EISSN: 1520-4812</identifier><identifier>DOI: 10.1021/bc200280g</identifier><identifier>PMID: 22304718</identifier><language>eng</language><publisher>United States: American Chemical Society</publisher><subject>Biocompatible Materials ; Cells, Cultured ; Chemical compounds ; Complement Activation ; Erythrocytes - cytology ; Fluorescence ; Glycerol - metabolism ; Glycerol - pharmacokinetics ; Humans ; Molecular weight ; Neoplasms - metabolism ; NMR ; Nuclear magnetic resonance ; Polymers - metabolism ; Polymers - pharmacokinetics ; Thrombelastography ; Tissue Distribution ; Tomography, Emission-Computed, Single-Photon ; Tumors</subject><ispartof>Bioconjugate chemistry, 2012-03, Vol.23 (3), p.372-381</ispartof><rights>Copyright © 2012 American Chemical Society</rights><rights>Copyright American Chemical Society Mar 21, 2012</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a341t-75ec4ab37ee03ab64e65fb1908de9497eb7cc0d26161825290a50f4d41a184873</citedby><cites>FETCH-LOGICAL-a341t-75ec4ab37ee03ab64e65fb1908de9497eb7cc0d26161825290a50f4d41a184873</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22304718$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Saatchi, Katayoun</creatorcontrib><creatorcontrib>Soema, Peter</creatorcontrib><creatorcontrib>Gelder, Nikolaus</creatorcontrib><creatorcontrib>Misri, Ripen</creatorcontrib><creatorcontrib>McPhee, Kelly</creatorcontrib><creatorcontrib>Baker, Jennifer H.E</creatorcontrib><creatorcontrib>Reinsberg, Stefan A</creatorcontrib><creatorcontrib>Brooks, Donald E</creatorcontrib><creatorcontrib>Häfeli, Urs O</creatorcontrib><title>Hyperbranched Polyglycerols as Trimodal Imaging Agents: Design, Biocompatibility, and Tumor Uptake</title><title>Bioconjugate chemistry</title><addtitle>Bioconjugate Chem</addtitle><description>Combining various imaging modalities often leads to complementary information and synergistic advantages. A trimodal long-circulating imaging agent tagged with radioactive, magnetic resonance, and fluorescence markers is able to combine the high sensitivity of SPECT with the high resolution of MRI over hours and days. The fluorescence marker helps to confirm the in vivo imaging information at the microscopic level, in the context of the tumor microenvironment. To make a trimodal long-circulating probe, high-molecular-weight hyperbranched polyglycerols (HPG) were modified with a suitable ligand for 111In radiolabeling and Gd coordination, and additionally tagged with a fluorescent dye. The resulting radiopharmaceutical and contrast agent was nontoxic and hemocompatible. Measured radioactively, its total tumor uptake increased from 2.6% at 24 h to 7.3% at 72 h, which is twice the increase expected due to tumor growth in this time period. Both in vivo MRI and subsequent histological analyses of the same tumors confirmed maximum HPG accumulation at 3 days post injection. Furthermore, Gd-derivatized HPG has an excellent contrast enhancement on T1-weighted MRI at 10× lower molar concentrations than commercially available Galbumin. HPG derivatized with gadolinium, radioactivity, and fluorescence are thus long-circulating macromolecules with great potential for imaging of healthy and leaky blood vessels using overlapping multimodal approaches and for the passive targeting of tumors.</description><subject>Biocompatible Materials</subject><subject>Cells, Cultured</subject><subject>Chemical compounds</subject><subject>Complement Activation</subject><subject>Erythrocytes - cytology</subject><subject>Fluorescence</subject><subject>Glycerol - metabolism</subject><subject>Glycerol - pharmacokinetics</subject><subject>Humans</subject><subject>Molecular weight</subject><subject>Neoplasms - metabolism</subject><subject>NMR</subject><subject>Nuclear magnetic resonance</subject><subject>Polymers - metabolism</subject><subject>Polymers - pharmacokinetics</subject><subject>Thrombelastography</subject><subject>Tissue Distribution</subject><subject>Tomography, Emission-Computed, Single-Photon</subject><subject>Tumors</subject><issn>1043-1802</issn><issn>1520-4812</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><recordid>eNplkD1PwzAURS0EoqUw8AeQhcSA1MCz4yQOWykfrVQJhnaObMcJKUkc7GTIvyeopQxM7w1H5-pehC4J3BGg5F4qCkA55EdoTAIKHuOEHg8_MN8jHOgInTm3BYCYcHqKRpT6wCLCx0gu-kZbaUWtPnSK303Z52WvtDWlw8LhtS0qk4oSLyuRF3WOZ7muW_eAn7Qr8nqKHwujTNWItpBFWbT9FIs6xeuuMhZvmlZ86nN0konS6Yv9naDNy_N6vvBWb6_L-WzlCZ-R1osCrZiQfqQ1-EKGTIdBJkkMPNUxiyMtI6UgpSEJhxIBjUEEkLGUEUE445E_Qdc7b2PNV6ddm2xNZ-shMokDFoWc-2yAbneQssY5q7OkGRoK2ycEkp8xk8OYA3u1F3ay0umB_F1vAG52gFDuL-y_6BsArXpb</recordid><startdate>20120321</startdate><enddate>20120321</enddate><creator>Saatchi, Katayoun</creator><creator>Soema, Peter</creator><creator>Gelder, Nikolaus</creator><creator>Misri, Ripen</creator><creator>McPhee, Kelly</creator><creator>Baker, Jennifer H.E</creator><creator>Reinsberg, Stefan A</creator><creator>Brooks, Donald E</creator><creator>Häfeli, Urs O</creator><general>American Chemical Society</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QO</scope><scope>7TM</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope></search><sort><creationdate>20120321</creationdate><title>Hyperbranched Polyglycerols as Trimodal Imaging Agents: Design, Biocompatibility, and Tumor Uptake</title><author>Saatchi, Katayoun ; Soema, Peter ; Gelder, Nikolaus ; Misri, Ripen ; McPhee, Kelly ; Baker, Jennifer H.E ; Reinsberg, Stefan A ; Brooks, Donald E ; Häfeli, Urs O</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a341t-75ec4ab37ee03ab64e65fb1908de9497eb7cc0d26161825290a50f4d41a184873</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Biocompatible Materials</topic><topic>Cells, Cultured</topic><topic>Chemical compounds</topic><topic>Complement Activation</topic><topic>Erythrocytes - cytology</topic><topic>Fluorescence</topic><topic>Glycerol - metabolism</topic><topic>Glycerol - pharmacokinetics</topic><topic>Humans</topic><topic>Molecular weight</topic><topic>Neoplasms - metabolism</topic><topic>NMR</topic><topic>Nuclear magnetic resonance</topic><topic>Polymers - metabolism</topic><topic>Polymers - pharmacokinetics</topic><topic>Thrombelastography</topic><topic>Tissue Distribution</topic><topic>Tomography, Emission-Computed, Single-Photon</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Saatchi, Katayoun</creatorcontrib><creatorcontrib>Soema, Peter</creatorcontrib><creatorcontrib>Gelder, Nikolaus</creatorcontrib><creatorcontrib>Misri, Ripen</creatorcontrib><creatorcontrib>McPhee, Kelly</creatorcontrib><creatorcontrib>Baker, Jennifer H.E</creatorcontrib><creatorcontrib>Reinsberg, Stefan A</creatorcontrib><creatorcontrib>Brooks, Donald E</creatorcontrib><creatorcontrib>Häfeli, Urs O</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Biotechnology Research Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><jtitle>Bioconjugate chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Saatchi, Katayoun</au><au>Soema, Peter</au><au>Gelder, Nikolaus</au><au>Misri, Ripen</au><au>McPhee, Kelly</au><au>Baker, Jennifer H.E</au><au>Reinsberg, Stefan A</au><au>Brooks, Donald E</au><au>Häfeli, Urs O</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Hyperbranched Polyglycerols as Trimodal Imaging Agents: Design, Biocompatibility, and Tumor Uptake</atitle><jtitle>Bioconjugate chemistry</jtitle><addtitle>Bioconjugate Chem</addtitle><date>2012-03-21</date><risdate>2012</risdate><volume>23</volume><issue>3</issue><spage>372</spage><epage>381</epage><pages>372-381</pages><issn>1043-1802</issn><eissn>1520-4812</eissn><abstract>Combining various imaging modalities often leads to complementary information and synergistic advantages. A trimodal long-circulating imaging agent tagged with radioactive, magnetic resonance, and fluorescence markers is able to combine the high sensitivity of SPECT with the high resolution of MRI over hours and days. The fluorescence marker helps to confirm the in vivo imaging information at the microscopic level, in the context of the tumor microenvironment. To make a trimodal long-circulating probe, high-molecular-weight hyperbranched polyglycerols (HPG) were modified with a suitable ligand for 111In radiolabeling and Gd coordination, and additionally tagged with a fluorescent dye. The resulting radiopharmaceutical and contrast agent was nontoxic and hemocompatible. Measured radioactively, its total tumor uptake increased from 2.6% at 24 h to 7.3% at 72 h, which is twice the increase expected due to tumor growth in this time period. Both in vivo MRI and subsequent histological analyses of the same tumors confirmed maximum HPG accumulation at 3 days post injection. Furthermore, Gd-derivatized HPG has an excellent contrast enhancement on T1-weighted MRI at 10× lower molar concentrations than commercially available Galbumin. HPG derivatized with gadolinium, radioactivity, and fluorescence are thus long-circulating macromolecules with great potential for imaging of healthy and leaky blood vessels using overlapping multimodal approaches and for the passive targeting of tumors.</abstract><cop>United States</cop><pub>American Chemical Society</pub><pmid>22304718</pmid><doi>10.1021/bc200280g</doi><tpages>10</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1043-1802
ispartof Bioconjugate chemistry, 2012-03, Vol.23 (3), p.372-381
issn 1043-1802
1520-4812
language eng
recordid cdi_proquest_journals_954768834
source American Chemical Society:Jisc Collections:American Chemical Society Read & Publish Agreement 2022-2024 (Reading list)
subjects Biocompatible Materials
Cells, Cultured
Chemical compounds
Complement Activation
Erythrocytes - cytology
Fluorescence
Glycerol - metabolism
Glycerol - pharmacokinetics
Humans
Molecular weight
Neoplasms - metabolism
NMR
Nuclear magnetic resonance
Polymers - metabolism
Polymers - pharmacokinetics
Thrombelastography
Tissue Distribution
Tomography, Emission-Computed, Single-Photon
Tumors
title Hyperbranched Polyglycerols as Trimodal Imaging Agents: Design, Biocompatibility, and Tumor Uptake
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T23%3A04%3A31IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Hyperbranched%20Polyglycerols%20as%20Trimodal%20Imaging%20Agents:%20Design,%20Biocompatibility,%20and%20Tumor%20Uptake&rft.jtitle=Bioconjugate%20chemistry&rft.au=Saatchi,%20Katayoun&rft.date=2012-03-21&rft.volume=23&rft.issue=3&rft.spage=372&rft.epage=381&rft.pages=372-381&rft.issn=1043-1802&rft.eissn=1520-4812&rft_id=info:doi/10.1021/bc200280g&rft_dat=%3Cproquest_cross%3E2620967211%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-a341t-75ec4ab37ee03ab64e65fb1908de9497eb7cc0d26161825290a50f4d41a184873%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=954768834&rft_id=info:pmid/22304718&rfr_iscdi=true